Researchers propose a stopgap measure to help Covid-19 patients in acute respiratory distress: a drug called tissue plasminogen activator, which dissolves blood clots.
Researchers propose a stopgap measure to help Covid-19 patients in acute respiratory distress: a drug called tissue plasminogen activator, which dissolves blood clots.